Skip to contentM
Merit Medical Systems Inc
M
MMSIMerit Medical Systems Inc Q2 2026 · 10-Q
Revenue$418.84M$418.84M+9.5% vs Q2 2025 Net Income$38.80M$38.80M+19.1% vs Q2 2025 EPS Diluted$0.65$0.65+20.4% vs Q2 2025 Gross Profit$215,166,000+16.6% Operating Income
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Merit Medical Systems Inc · CIK 856982 · Engraved from SEC EDGAR
Operating Cash Flowderived$69,276,000−16.8% Free Cash Flowderived$51,945,000−25.3% Margins · derivedGross margin51.4%+3.1 pt vs Q2 2025
Operating margin14.4%+2.2 pt vs Q2 2025
Net margin9.3%+0.7 pt vs Q2 2025
ended Jun 30, 2026 · filed Jul 30, 2026 · 30 d after period end